Herbs (Global Traditional) · European
Symphytum officinale (Comfrey)
Moderate Evidencebotanical3 PubMed Studies
Hermetica Superfood Encyclopedia
Symphytum officinale (comfrey) contains allantoin and rosmarinic acid that promote tissue repair and reduce inflammation. The herb demonstrates antioxidant activity with ABTS scavenging IC50 of 0.33 μg/mL and traditional use for wound healing.
Symphytum officinale (comfrey) is a perennial herb native to Europe and western Asia, belonging to the Boraginaceae family. The plant's roots, leaves, and shoots are harvested and processed using traditional solvent extraction or modern natural deep eutectic solvents (NADES) like betaine-urea to selectively isolate beneficial compounds while minimizing toxic pyrrolizidine alkaloids.
No human clinical trials, RCTs, or meta-analyses were found in the available research for Symphytum officinale. Current scientific literature focuses primarily on chemical composition analysis, extraction optimization studies, and toxicity concerns related to pyrrolizidine alkaloid content rather than therapeutic efficacy in humans.
No clinically studied dosage ranges are available for comfrey due to absence of human trials. Research focuses on extraction methods targeting rosmarinic acid (1.934 mg/g in optimized extracts) while minimizing toxic pyrrolizidine alkaloids. Due to hepatotoxicity risks from pyrrolizidine alkaloids, internal use is not recommended. Consult a healthcare provider before starting any new supplement.
Comfrey (Symphytum officinale) is not typically consumed as a food source due to hepatotoxic pyrrolizidine alkaloid (PA) content, but its phytochemical and nutritional composition is well-characterized. Bioactive compounds dominate its profile: allantoin (0.8% dry weight in roots, 0.4% in leaves) is the primary wound-healing constituent promoting cell proliferation; rosmarinic acid (0.87–2.6% in leaves) is the dominant phenolic acid with antioxidant and anti-inflammatory properties; pyrrolizidine alkaloids (0.02–0.17% in roots, lower in leaves) including symphytine, echimidine, and lycopsamine are hepatotoxic and limit internal use. Mucilage polysaccharides (approximately 29% in roots) contribute to its demulcent properties. Tannins are present at approximately 2.4–4.5% in roots. Additional phenolics include chlorogenic acid, caffeic acid, and lithospermic acid. Mineral content includes notable silica, calcium (approximately 150 mg/100g fresh leaf), potassium, and phosphorus. Crude protein in fresh leaves reaches approximately 20–35% of dry weight, comparable to legumes, with a broad amino acid profile — historically noted in permaculture contexts. Crude fiber is approximately 8–12% dry weight. Vitamin content includes beta-carotene (pro-vitamin A precursor) and vitamin B12 traces reported in some analyses, though B12 data remains contested. Bioavailability of allantoin and rosmarinic acid is considered moderate via topical application; internal bioavailability is restricted by regulatory limits on PA exposure (EMA guideline: maximum 1 μg PA/day for external use products, internal use not recommended).
Comfrey's allantoin stimulates cell proliferation and tissue regeneration by enhancing protein synthesis in damaged tissues. Rosmarinic acid inhibits complement activation at inflammation sites, reducing inflammatory cascade responses. The herb's antioxidant compounds neutralize free radicals through direct scavenging mechanisms.
Current evidence for comfrey consists primarily of in vitro studies demonstrating antioxidant activity with ABTS scavenging IC50 of 0.33 μg/mL. Mechanism studies show rosmarinic acid's complement inhibition properties, but human clinical trials are limited. Traditional use data supports wound healing applications, though controlled clinical evidence remains insufficient. Most research focuses on topical preparations due to safety concerns with internal use.
Comfrey contains pyrrolizidine alkaloids that can cause hepatotoxicity and are potentially carcinogenic with oral use. Topical preparations are generally considered safer but should be used only on intact skin for limited periods. Internal use is contraindicated during pregnancy, breastfeeding, and in individuals with liver disease. No specific drug interactions documented, but liver-metabolized medications may be affected due to hepatotoxic potential.
